Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics
SRPT Price/Volume Stats
Current price | $129.46 | 52-week high | $159.89 |
Prev. close | $130.23 | 52-week low | $55.25 |
Day low | $127.83 | Volume | 786,422 |
Day high | $131.16 | Avg. volume | 1,072,504 |
50-day MA | $125.68 | Dividend yield | N/A |
200-day MA | $111.04 | Market Cap | 12.16B |
SRPT Stock Price Chart Interactive Chart >
SRPT POWR Grades
- Growth is the dimension where SRPT ranks best; there it ranks ahead of 93.58% of US stocks.
- SRPT's strongest trending metric is Quality; it's been moving down over the last 26 weeks.
- SRPT ranks lowest in Stability; there it ranks in the 16th percentile.
SRPT Stock Summary
- With a one year PEG ratio of 184.84, SAREPTA THERAPEUTICS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 83.94% of US stocks.
- Of note is the ratio of SAREPTA THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; only 15.89% of US stocks have a lower such ratio.
- SRPT's price/sales ratio is 7.93; that's higher than the P/S ratio of 86.54% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to SAREPTA THERAPEUTICS INC are DCPH, CRIS, BCDA, CBAY, and RXRX.
- Visit SRPT's SEC page to see the company's official filings. To visit the company's web site, go to www.sarepta.com.
SRPT Valuation Summary
- In comparison to the median Healthcare stock, SRPT's price/sales ratio is 272.73% higher, now standing at 8.2.
- Over the past 243 months, SRPT's price/earnings ratio has gone down 4.6.
Below are key valuation metrics over time for SRPT.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
SRPT | 2023-12-29 | 8.2 | 11.8 | -13.1 | -14.9 |
SRPT | 2023-12-28 | 8.3 | 12.0 | -13.2 | -15.1 |
SRPT | 2023-12-27 | 8.2 | 11.9 | -13.1 | -14.9 |
SRPT | 2023-12-26 | 8.2 | 11.8 | -13.0 | -14.9 |
SRPT | 2023-12-22 | 8.0 | 11.6 | -12.8 | -14.6 |
SRPT | 2023-12-21 | 7.7 | 11.1 | -12.3 | -14.1 |
SRPT Growth Metrics
- Its 5 year revenue growth rate is now at 1772.43%.
- Its year over year net cashflow from operations growth rate is now at 48.06%.
- Its 5 year cash and equivalents growth rate is now at 540.35%.
The table below shows SRPT's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 876.047 | -262.28 | -716.225 |
2022-06-30 | 835.184 | -321.645 | -506.631 |
2022-03-31 | 765.786 | -363.976 | -356.555 |
2021-12-31 | 701.887 | -443.172 | -418.78 |
2021-09-30 | 645.564 | -588.381 | -486.116 |
2021-06-30 | 600.082 | -702.238 | -634.471 |
SRPT's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SRPT has a Quality Grade of C, ranking ahead of 59.75% of graded US stocks.
- SRPT's asset turnover comes in at 0.231 -- ranking 185th of 682 Pharmaceutical Products stocks.
- ORMP, AGIO, and JAZZ are the stocks whose asset turnover ratios are most correlated with SRPT.
The table below shows SRPT's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.231 | 0.864 | -0.249 |
2021-06-30 | 0.213 | 0.868 | -0.332 |
2021-03-31 | 0.201 | 0.872 | -0.375 |
2020-12-31 | 0.186 | 0.883 | -0.313 |
2020-09-30 | 0.190 | 0.886 | -0.376 |
2020-06-30 | 0.192 | 0.879 | -0.357 |
SRPT Price Target
For more insight on analysts targets of SRPT, see our SRPT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $118.39 | Average Broker Recommendation | 1.5 (Moderate Buy) |
Sarepta Therapeutics, Inc. (SRPT) Company Bio
Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.
Latest SRPT News From Around the Web
Below are the latest news stories about SAREPTA THERAPEUTICS INC that investors may wish to consider to help them evaluate SRPT as an investment opportunity.
3 Things About Sarepta Therapeutics Every Smart Investor KnowsMastering this stock requires appreciating a few scientific nuances. |
15 Best Fast Growth Stocks to Buy NowIn this article, we will take a look at the 15 best fast growth stocks to buy now. To skip our analysis of the recent trends, and market activity, you can go directly to see the 5 Best Fast Growth Stocks to Buy Now. Vanguard Growth ETF is one of the most famous growth focused […] |
13 High Growth Healthcare Stocks to BuyIn this article, we will take a look at 13 high growth healthcare stocks to buy. To skip our analysis of the recent market activity, you can go directly to see the 5 Best High Growth Healthcare Stocks to Buy. For the purpose of this article, we have defined high growth stocks as stocks that […] |
Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the DayFluor Corporation and Align Technology are part of the Zacks Bull and Bear of the Day article. |
Sarepta Therapeutics Seen Expanding Duchenne Treatment LabelSarepta Therapeutics may be on the cusp of expanding the label for its Duchenne Muscular Dystrophy treatment, according to Mizuho analyst Uy Ear. The company has submitted an efficacy supplement to the FDA for Elevidys, requesting expanded approval for all DMD patients. The treatment's current label restricts its use to 4- to 5-year-old ambulatory patients. |
SRPT Price Returns
1-mo | -8.53% |
3-mo | 34.25% |
6-mo | 6.80% |
1-year | -5.20% |
3-year | 79.18% |
5-year | 8.62% |
YTD | 34.25% |
2023 | -25.58% |
2022 | 43.90% |
2021 | -47.18% |
2020 | 32.12% |
2019 | 18.24% |
Continue Researching SRPT
Want to see what other sources are saying about Sarepta Therapeutics Inc's financials and stock price? Try the links below:Sarepta Therapeutics Inc (SRPT) Stock Price | Nasdaq
Sarepta Therapeutics Inc (SRPT) Stock Quote, History and News - Yahoo Finance
Sarepta Therapeutics Inc (SRPT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...